256 related articles for article (PubMed ID: 11650667)
21. Policy formulation and technology assessment.
Banta HD; Behney CJ
Milbank Mem Fund Q Health Soc; 1981; 59(3):445-79. PubMed ID: 6792555
[TBL] [Abstract][Full Text] [Related]
22. Economic evaluation of medical technologies.
Seifan A; Shemer J
Isr Med Assoc J; 2005 Feb; 7(2):67-70. PubMed ID: 15729952
[TBL] [Abstract][Full Text] [Related]
23. Too much medical technology?
Hiatt HH
Wall St J (East Ed); 1976 Jun; ():16. PubMed ID: 11648873
[No Abstract] [Full Text] [Related]
24. A primer on the assessment of medical technologies.
Matuszewski KA
Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160
[TBL] [Abstract][Full Text] [Related]
25. [Medical-economic analysis: a necessary complement to "evidence based medicine"].
Wasserfallen JB
Rev Med Suisse Romande; 2001 Apr; 121(4):265-8. PubMed ID: 11400397
[TBL] [Abstract][Full Text] [Related]
26. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
Philipson TJ; Jena AB
AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
[No Abstract] [Full Text] [Related]
27. Expected value of information and decision making in HTA.
Eckermann S; Willan AR
Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
[TBL] [Abstract][Full Text] [Related]
28. The sex-bias myth in medicine.
Kadar AG
Atl Mon; 1994 Aug; 274(2):66-70. PubMed ID: 11659876
[No Abstract] [Full Text] [Related]
29. The impact of technology on health care cost and policy development.
Wallner PE; Konski A
Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
[TBL] [Abstract][Full Text] [Related]
30. Medical technology management: bridging the gap between theory and practice.
Shemer J; Abadi-Korek I; Seifan A
Isr Med Assoc J; 2005 Apr; 7(4):211-5. PubMed ID: 15847198
[TBL] [Abstract][Full Text] [Related]
31. Are economic evaluations and health technology assessments increasingly demanded in times of rationing health services? The case of the Argentine financial crisis.
Rubinstein A; Belizán M; Discacciati V
Int J Technol Assess Health Care; 2007; 23(2):169-76. PubMed ID: 17493302
[TBL] [Abstract][Full Text] [Related]
32. Emerging technologies and medical coverage.
Merrikin K; Smith S
Clin Ethics Rep; 1996; 10(1):9-12. PubMed ID: 11660222
[No Abstract] [Full Text] [Related]
33. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
34. Role of emerging technology in the era of cost containment.
Soetikno R; Young HS; Keeffe EB
Gastrointest Endosc Clin N Am; 1997 Apr; 7(2):331-9. PubMed ID: 9101270
[TBL] [Abstract][Full Text] [Related]
35. The clinical context of technology assessment.
Smits HL
J Health Polit Policy Law; 1984; 9(1):31-40. PubMed ID: 6736598
[TBL] [Abstract][Full Text] [Related]
36. Older Americans and the rationing of health care.
Smith AH; Rother J
Univ PA Law Rev; 1992 May; 140(5):1847-57. PubMed ID: 11651597
[No Abstract] [Full Text] [Related]
37. Technology assessment: measuring the outcomes of laboratory practice.
Wilkinson DS
Clin Leadersh Manag Rev; 2000; 14(6):267-71. PubMed ID: 11210211
[TBL] [Abstract][Full Text] [Related]
38. Public healthcare resource allocation and the Rule of Rescue.
Cookson R; McCabe C; Tsuchiya A
J Med Ethics; 2008 Jul; 34(7):540-4. PubMed ID: 18591290
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of biotechnology-based healthcare products for prioritization in Indian context.
Visalakshi S; Mohan S
Int J Technol Assess Health Care; 2002; 18(3):718-27. PubMed ID: 12391962
[TBL] [Abstract][Full Text] [Related]
40. Mock hospital ethics committee: the role of ethics committees in resource distribution.
Bergen SS; Burks W; Nadler G; Olick R; Pickens R; Spiro H
Trends Health Care Law Ethics; 1992; 7(3-4):50-6. PubMed ID: 11651473
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
